Results 1 to 10 of about 432,090 (383)
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors’ clinical recommendations.
T. Shamsi
semanticscholar +4 more sources
Introduction Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet count (
J. Bussel +4 more
semanticscholar +5 more sources
Clinical and Molecular Spectrum of MYH9-Thrombocytopenia: Insights from a Single Centric Pediatric Cohort. [PDF]
Obrisca R +8 more
europepmc +3 more sources
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Background Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1
A. Greinacher +5 more
semanticscholar +2 more sources
Cyclic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia (ITP): Diagnostic and Therapeutic Lessons. [PDF]
Seeburun S +3 more
europepmc +3 more sources
Thrombocytopenia in hypertensive disorder of pregnancy: maternal and perinatal outcome [PDF]
Background: Pregnancy induced hypertension (PIH) is one of the most common causes of both maternal and neonatal morbidity. A variety of haematological abnormalities may occur in women with PIH of which thrombocytopenia is the most common.
Varsha Deshmukh +2 more
doaj +1 more source
Understanding Immune Thrombocytopenia: Looking Out of the Box
The pathogenesis of immune thrombocytopenia (ITP) is increasingly being elucidated, and its etiology is becoming more frequently identified, leading to a diagnostic shift from primary to secondary ITP.
Alexandra Schifferli +8 more
doaj +1 more source
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Summary We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19).
N. H. Schultz +10 more
semanticscholar +1 more source
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a new syndrome associated with the ChAdOx1 nCoV-19 adenoviral vector vaccine against severe acute respiratory syndrome coronavirus 2. Data are lacking on the clinical features of
S. Pavord +8 more
semanticscholar +1 more source
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
The coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulated the development of highly effective vaccines that were produced wi...
D. Cines, J. Bussel
semanticscholar +1 more source

